{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:23:59Z","timestamp":1768836239977,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/cmi.2017.140","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T16:25:07Z","timestamp":1517847907000},"page":"610-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comprehensive review of autoantibodies in patients with hyper-IgM syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Mohamed-Ridha","family":"Barbouche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qubo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Ben-Mustapha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakera","family":"Shums","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Trifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Malinverno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bernuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nourhen","family":"Agrebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nri2849","volume":"10","author":"MR Ehrenstein","year":"2010","unstructured":"Ehrenstein MR, Notley CA. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 2010; 10: 778\u2013786.","journal-title":"Nat Rev Immunol"},{"key":"127_CR2","doi-asserted-by":"publisher","first-page":"A404","DOI":"10.1016\/j.autrev.2011.12.001","volume":"11","author":"C Duarte-Rey","year":"2012","unstructured":"Duarte-Rey C, Bogdanos DP, Leung PS, Anaya JM, Gershwin ME. IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev 2012; 11: A404\u2013A412.","journal-title":"Autoimmun Rev"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00431-011-1400-2","volume":"170","author":"NE Karaca","year":"2011","unstructured":"Karaca NE, Durandy A, Gulez N, Aksu G, Kutukculer N. Study of patients with hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature. Eur J Pediatr 2011; 170: 1039\u20131047.","journal-title":"Eur J Pediatr"},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","volume":"149","author":"EG Davies","year":"2010","unstructured":"Davies EG, Thrasher AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol 2010; 149: 167\u2013180.","journal-title":"Br J Haematol"},{"key":"127_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1084\/jem.20062287","volume":"204","author":"M Herve","year":"2007","unstructured":"Herve M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007; 204: 1583\u20131593.","journal-title":"J Exp Med"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1046\/j.1365-2133.1998.02278.x","volume":"138","author":"KA Wolpert","year":"1998","unstructured":"Wolpert KA, Webster AD, Whittaker SJ. Discoid lupus erythematosus associated with a primary immunodeficiency syndrome showing features of non-X-linked hyper-IgM syndrome. Br J Dermatol 1998; 138: 1053\u20131057.","journal-title":"Br J Dermatol"},{"key":"127_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/00002281-200307000-00009","volume":"15","author":"AV Gulino","year":"2003","unstructured":"Gulino AV, Notarangelo LD. Hyper IgM syndromes. Curr Opin Rheumatol 2003; 15: 422\u2013429.","journal-title":"Curr Opin Rheumatol"},{"key":"127_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","volume":"203","author":"V Lougaris","year":"2005","unstructured":"Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005; 203: 48\u201366.","journal-title":"Immunol Rev"},{"issue":"(Suppl 1)","key":"127_CR9","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1007\/s10875-008-9171-x","volume":"28","author":"AA Jesus","year":"2008","unstructured":"Jesus AA, Duarte AJ, Oliveira JB. Autoimmunity in hyper-IgM syndrome. J Clin Immunol 2008; 28 (Suppl 1): S62\u2013S66.","journal-title":"J Clin Immunol"},{"key":"127_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00251-015-0878-6","volume":"68","author":"H Ouadani","year":"2016","unstructured":"Ouadani H, Ben-Mustapha I, Ben-ali M, Ben-khemis L, Largu\u00e8che B, Boussoffara R et al. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients. Immunogenetics 2016; 68: 19\u201328.","journal-title":"Immunogenetics"},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2016.09.025","volume":"79","author":"H Ouadani","year":"2016","unstructured":"Ouadani H, Ben-Mustapha I, Ben-Ali M, Largu\u00e8che B, Jovanic T, Garcia S et al. Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate. Mol Immunol. 2016; 79: 77\u201382.","journal-title":"Mol Immunol."},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","volume":"158","author":"AR Hayward","year":"1997","unstructured":"Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997; 158: 977\u2013983.","journal-title":"J Immunol"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","volume":"110","author":"P Quartier","year":"2004","unstructured":"Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 2004; 110: 22\u201329.","journal-title":"Clin Immunol"},{"key":"127_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","volume":"135","author":"P Muratori","year":"2004","unstructured":"Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S et al. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 2004; 135: 154\u2013158.","journal-title":"Clin Exp Immunol"},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/jhep.2001.26514","volume":"34","author":"H Miyakawa","year":"2001","unstructured":"Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243\u2013248.","journal-title":"Hepatology"},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261\u20131273.","journal-title":"N Engl J Med"},{"key":"127_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/bega.2000.0108","volume":"14","author":"FH Wolfhagen","year":"2000","unstructured":"Wolfhagen FH, van Buuren HR, Vleggaar FP, Schalm SW. Management of osteoporosis in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 629\u2013641.","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/s-2007-979469","volume":"27","author":"P Invernizzi","year":"2007","unstructured":"Invernizzi P, Lleo A, Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007; 27: 161\u2013172.","journal-title":"Semin Liver Dis"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liver","year":"2009","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237\u2013267.","journal-title":"J Hepatol"},{"key":"127_CR20","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.gastro.2003.08.022","volume":"125","author":"Y Dahlan","year":"2003","unstructured":"Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ et al. Pediatric-onset primary biliary cirrhosis. Gastroenterology 2003; 125: 1476\u20131479.","journal-title":"Gastroenterology"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","volume":"174","author":"ME Gershwin","year":"2000","unstructured":"Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000; 174: 210\u2013225.","journal-title":"Immunol Rev"},{"key":"127_CR22","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1073\/pnas.95.17.10089","volume":"95","author":"MR Ehrenstein","year":"1998","unstructured":"Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 1998; 95: 10089\u201310093.","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1568-9972(01)00020-9","volume":"1","author":"SA Long","year":"2002","unstructured":"Long SA, Van de Water J, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev 2002; 1: 37\u201342.","journal-title":"Autoimmun Rev"},{"key":"127_CR24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","volume":"38","author":"C Selmi","year":"2003","unstructured":"Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38: 1250\u20131257.","journal-title":"Hepatology"},{"key":"127_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.24630","volume":"55","author":"A Lleo","year":"2012","unstructured":"Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2012; 55: 153\u2013160.","journal-title":"Hepatology"},{"key":"127_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/01.bor.0000130538.76808.c2","volume":"16","author":"C Selmi","year":"2004","unstructured":"Selmi C, Gershwin ME. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol 2004; 16: 406\u2013410.","journal-title":"Curr Opin Rheumatol"},{"key":"127_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1155\/2010\/752314","volume":"29","author":"C Selmi","year":"2010","unstructured":"Selmi C, De Santis M, Cavaciocchi F, Gershwin ME. Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis. Dis Markers 2010; 29: 287\u2013299.","journal-title":"Dis Markers"},{"key":"127_CR28","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jhep.2003.11.033","volume":"40","author":"AS Abdulkarim","year":"2004","unstructured":"Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol 2004; 40: 380\u2013384.","journal-title":"J Hepatol"},{"key":"127_CR29","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gut.17.11.844","volume":"17","author":"HC Thomas","year":"1976","unstructured":"Thomas HC, Holden R, Jones JV, Peacock DB. Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis. Gut 1976; 17: 844\u2013848.","journal-title":"Gut"},{"key":"127_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s005350050380","volume":"34","author":"M Nakajima","year":"1999","unstructured":"Nakajima M, Shimizu H, Miyazaki A, Watanabe S, Kitami N, Sato N. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? J Gastroenterol 1999; 34: 607\u2013612.","journal-title":"J Gastroenterol"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi2017140","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi2017140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cmi.2017.140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cmi2017140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:27:47Z","timestamp":1693517267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi2017140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2017.140","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}